170 related articles for article (PubMed ID: 22449726)
1. Hydroxysafflor yellow A induces apoptosis in activated hepatic stellate cells through ERK1/2 pathway in vitro.
Li CC; Yang CZ; Li XM; Zhao XM; Zou Y; Fan L; Zhou L; Liu JC; Niu YC
Eur J Pharm Sci; 2012 Aug; 46(5):397-404. PubMed ID: 22449726
[TBL] [Abstract][Full Text] [Related]
2. Hydroxysafflor yellow A protects against chronic carbon tetrachloride-induced liver fibrosis.
Zhang Y; Guo J; Dong H; Zhao X; Zhou L; Li X; Liu J; Niu Y
Eur J Pharmacol; 2011 Jun; 660(2-3):438-44. PubMed ID: 21536026
[TBL] [Abstract][Full Text] [Related]
3. Icaritin induces cell death in activated hepatic stellate cells through mitochondrial activated apoptosis and ameliorates the development of liver fibrosis in rats.
Li J; Liu P; Zhang R; Cao L; Qian H; Liao J; Xu W; Wu M; Yin Z
J Ethnopharmacol; 2011 Sep; 137(1):714-23. PubMed ID: 21726622
[TBL] [Abstract][Full Text] [Related]
4. Tetramethylpyrazine induces G0/G1 cell cycle arrest and stimulates mitochondrial-mediated and caspase-dependent apoptosis through modulating ERK/p53 signaling in hepatic stellate cells in vitro.
Zhang F; Kong DS; Zhang ZL; Lei N; Zhu XJ; Zhang XP; Chen L; Lu Y; Zheng SZ
Apoptosis; 2013 Feb; 18(2):135-49. PubMed ID: 23247439
[TBL] [Abstract][Full Text] [Related]
5. New insights into the antifibrotic effects of sorafenib on hepatic stellate cells and liver fibrosis.
Wang Y; Gao J; Zhang D; Zhang J; Ma J; Jiang H
J Hepatol; 2010 Jul; 53(1):132-44. PubMed ID: 20447716
[TBL] [Abstract][Full Text] [Related]
6. Activation of PPARγ is required for hydroxysafflor yellow A of Carthamus tinctorius to attenuate hepatic fibrosis induced by oxidative stress.
Wang CY; Liu Q; Huang QX; Liu JT; He YH; Lu JJ; Bai XY
Phytomedicine; 2013 May; 20(7):592-9. PubMed ID: 23523101
[TBL] [Abstract][Full Text] [Related]
7. Lovastatin protects mesenchymal stem cells against hypoxia- and serum deprivation-induced apoptosis by activation of PI3K/Akt and ERK1/2.
Xu R; Chen J; Cong X; Hu S; Chen X
J Cell Biochem; 2008 Jan; 103(1):256-69. PubMed ID: 17497701
[TBL] [Abstract][Full Text] [Related]
8. Hydroxysafflor yellow A attenuates carbon tetrachloride-induced hepatic fibrosis in rats by inhibiting ERK5 signaling.
Zhang YB; Dong HY; Zhao XM; Fan L; Zou Y; Zhang C; Li G; Liu JC; Niu YC
Am J Chin Med; 2012; 40(3):481-94. PubMed ID: 22745065
[TBL] [Abstract][Full Text] [Related]
9. Increased contractility of hepatic stellate cells in cirrhosis is mediated by enhanced Ca2+-dependent and Ca2+-sensitization pathways.
Iizuka M; Murata T; Hori M; Ozaki H
Am J Physiol Gastrointest Liver Physiol; 2011 Jun; 300(6):G1010-21. PubMed ID: 21393429
[TBL] [Abstract][Full Text] [Related]
10. Ligustrazine attenuates oxidative stress-induced activation of hepatic stellate cells by interrupting platelet-derived growth factor-β receptor-mediated ERK and p38 pathways.
Zhang F; Ni C; Kong D; Zhang X; Zhu X; Chen L; Lu Y; Zheng S
Toxicol Appl Pharmacol; 2012 Nov; 265(1):51-60. PubMed ID: 23022513
[TBL] [Abstract][Full Text] [Related]
11. Propofol post-conditioning protects against cardiomyocyte apoptosis in hypoxia/reoxygenation injury by suppressing nuclear factor-kappa B translocation via extracellular signal-regulated kinase mitogen-activated protein kinase pathway.
Li H; Tan J; Zou Z; Huang CG; Shi XY
Eur J Anaesthesiol; 2011 Jul; 28(7):525-34. PubMed ID: 21666544
[TBL] [Abstract][Full Text] [Related]
12. Apoptosis of liver cancer cells by vitamin K2 and enhancement by MEK inhibition.
Matsumoto K; Okano J; Nagahara T; Murawaki Y
Int J Oncol; 2006 Dec; 29(6):1501-8. PubMed ID: 17088989
[TBL] [Abstract][Full Text] [Related]
13. Effect of Hydroxysafflor yellow A on human umbilical vein endothelial cells under hypoxia.
Ji DB; Zhang LY; Li CL; Ye J; Zhu HB
Vascul Pharmacol; 2009; 50(3-4):137-45. PubMed ID: 19084079
[TBL] [Abstract][Full Text] [Related]
14. Hydroxysafflor yellow A enhances survival of vascular endothelial cells under hypoxia via upregulation of the HIF-1 alpha-VEGF pathway and regulation of Bcl-2/Bax.
Ji DB; Zhu MC; Zhu B; Zhu YZ; Li CL; Ye J; Zhu HB
J Cardiovasc Pharmacol; 2008 Aug; 52(2):191-202. PubMed ID: 18670359
[TBL] [Abstract][Full Text] [Related]
15. Hydroxysafflor yellow A suppresses liver fibrosis induced by carbon tetrachloride with high-fat diet by regulating PPAR-γ/p38 MAPK signaling.
Liu Q; Wang CY; Liu Z; Ma XS; He YH; Chen SS; Bai XY
Pharm Biol; 2014 Sep; 52(9):1085-93. PubMed ID: 24618007
[TBL] [Abstract][Full Text] [Related]
16. Plumbagin induces cell cycle arrest and apoptosis through reactive oxygen species/c-Jun N-terminal kinase pathways in human melanoma A375.S2 cells.
Wang CC; Chiang YM; Sung SC; Hsu YL; Chang JK; Kuo PL
Cancer Lett; 2008 Jan; 259(1):82-98. PubMed ID: 18023967
[TBL] [Abstract][Full Text] [Related]
17. Paeonol inhibits hepatic fibrogenesis via disrupting nuclear factor-κB pathway in activated stellate cells: in vivo and in vitro studies.
Kong D; Zhang F; Wei D; Zhu X; Zhang X; Chen L; Lu Y; Zheng S
J Gastroenterol Hepatol; 2013 Jul; 28(7):1223-33. PubMed ID: 23425217
[TBL] [Abstract][Full Text] [Related]
18. Decreased expression of p38 MAPK mediates protective effects of hydrogen sulfide on hepatic fibrosis.
Fan HN; Wang HJ; Ren L; Ren B; Dan CR; Li YF; Hou LZ; Deng Y
Eur Rev Med Pharmacol Sci; 2013 Mar; 17(5):644-52. PubMed ID: 23543448
[TBL] [Abstract][Full Text] [Related]
19. The endocannabinoid N-arachidonoyl dopamine (NADA) selectively induces oxidative stress-mediated cell death in hepatic stellate cells but not in hepatocytes.
Wojtalla A; Herweck F; Granzow M; Klein S; Trebicka J; Huss S; Lerner R; Lutz B; Schildberg FA; Knolle PA; Sauerbruch T; Singer MV; Zimmer A; Siegmund SV
Am J Physiol Gastrointest Liver Physiol; 2012 Apr; 302(8):G873-87. PubMed ID: 22301114
[TBL] [Abstract][Full Text] [Related]
20. Tanshinone II A induces apoptosis and S phase cell cycle arrest in activated rat hepatic stellate cells.
Che XH; Park EJ; Zhao YZ; Kim WH; Sohn DH
Basic Clin Pharmacol Toxicol; 2010 Jan; 106(1):30-7. PubMed ID: 19906051
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
